THE BIG PICTURE ON SMALL MEDICINE: THE STATE OF NANOMEDICINE PRODUCTS APPROVED FOR USE OR IN CLINICAL TRIALS

By M. Etheridge, Stephen A. Campbell, A. Erdman, Christy L. Haynes, S. Wolf, J. McCullough. Nanomedicine: Nanotechnology, Biology and Medicine, 2012

962 citations recorded by the source corpus.

Developments in nanomedicine are expected to provide solutions to many of modern medicine’s unsolved problems, so it is no surprise that literature is flush with articles discussing the subject. However, existing reviews tend to focus on specific sectors of nanomedicine or take a very forward looking stance and fail to provide a complete perspective on the current landscape. This article provides a more comprehensive and contemporary inventory of nanomedicine products. A keyword search of literature, clinical trial registries, and the Web, yielded 247 nanomedicine products that are approved or in various stages of clinical study. Specific information on each was gathered, so the overall field could be described based on various dimensions, including: FDA classification, approval status, nanoscale size, treated condition, nanostructure, and others. In addition to documenting the large number of nanomedicine products already in human use, this study indentifies some interesting trends forecasting the future of nanomedicine.

Subfields: Biomaterials, Biomedical Engineering, Oncology

View Paper: https://www.semanticscholar.org/paper/375b212d0a4aa9732f531200cc839ba32dcbcbfc

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomaterials

1. K. El-Say
2. Hossam S. El-Sawy
3. Ning Gu
4. F. Xiong
5. Fang Yang
6. A. Molinari
7. Dong Liu
8. Giuseppina Bozzuto

In Biomedical Engineering

1. K. El-Say
2. Hossam S. El-Sawy
3. A. Molinari
4. Giuseppina Bozzuto

In Oncology

1. K. El-Say
2. Hossam S. El-Sawy

Citations in the corpus

• Polymeric nanoparticles: Promising platform for drug delivery. (2017, background): “Besides, additional categorization data concerning nanoparticles such as nanoparticles morphology, shape, size, size distribution, and other more specific physic-chemical information as surface additives and coatings effect in appropriate systems (Bamrungsap et al., 2012; Bobo et al., 2016; Desai, 2”
• Green synthesis of silver nanoparticles with antimicrobial and azo dye (Congo red) degradation properties using Amaranthus gangeticus Linn leaf extract (2015, background): “…(Kalidindi and Jadirdar 2012), photonics (Shen et al. 2000), chemical and bio-sensing (Zayats et al. 2003), medicine (Jotterand and Alexander 2011; Etheridge et al. 2013) etc. Nano crystalline silver is well known for possessing an inhibitory effect towards many bacterial stains and…”
• Liposomes as nanomedical devices (2015, background): “However, liposomes applied to medical use range between 50 and 450 nm.(3) Liposomes seem to be an almost ideal drug-carrier system, since their morphol-”
• Techniques for physicochemical characterization of nanomaterials (2013, background): “…as NP and its derivatives, liposome, micelle, dendrimer/fleximer, virosome, emulsion, quantum dot, fullerene, carbon nanotube and hydrogel, and each type may consist of polymers, metals and metal oxides, lipids, proteins, DNA or other organic compounds (Etheridge et al., 2013; Patri et al., 2006).”
• The Smart Drug Delivery System and Its Clinical Potential (2016, background): “AuroShell Intracranial tumors Thermosensitive gold nanoshell Nanospectra Biosciences Phase I [188, 189]”